30 March 2015:
CNBP celebrated a successful launch with industry partner Heraeus, in Hanau, Germany on the 30th March 2015.
Taking place at the Heraeus Quarzglas division, the launch was attended by CNBP Investigator A/Prof Heike Ebendorff-Heidepriem and hosted by Dr Gerhard Schoetz, General Manager of Heraeus Specialty Fiber Optics.
As part of the launch, Ebendorff-Heidepriem met with a number of senior Heraeus executives, provided a presentation about the optical fiber sensor research taking place at CNBP, provided an overview of the CNBP (the scope of the research themes and the biological challenges that the CNBP aims to solve), and talked through related photonics research taking place across Australia.
Ebendorff-Heidepriem and Heraeus executives also discussed a wide range of topics during the launch, including the properties of different silica types and behaviors, particularly relating to extrusion and fiber drawing processes. Information on silica items in stock and silica items that could be made on demand was also provided and agreement on the supply of F110 silica rods to fabricate UV transmitting silica fiber was also made.
Heraeus, the world’s largest manufacturer of synthetic fused silica brings to the CNBP longstanding and extensive knowledge in silica glass types and properties. The corporation’s expertise will be critical for the fabrication of specialty silica fibers and for the selection and development of suitable silica types for specific fiber sensor application, for use within the CNBP.
The launch was highly successful, strengthening industry and research links across the CNBP, with the possibility of Heraeus attendance at related Australasian conferences and at the annual CNBP retreat also discussed.
27 March 2015:
CNBP’s University of Adelaide workshop series took place March 25-27th 2015, to a full and interested crowd of CNBP researchers, associate investigators and partners.
Activities included a visit to the University Medical School Laboratories to better understand capabilities first hand, as well as a visit to the South Australian Health and Medical Research Institute (SAHMRI).
Also featuring, were workshops and discussions on CNBP’s ‘Pain projects’, Nitric Oxide (NO) probes and Epigenetics sensing.
26 March 2015:
The CNBP recently completed an extremely successful visit to Canberra, taking part in ‘Science Meets Parliament’, an event coordinated by Science and Technology Australia.
The event brought together 200 working scientists for a two-day program of professional development and networking, aimed at helping them better communicate their science to the media, policymakers and parliamentarians.
CNBP Chief Investigators and researchers met with Malcolm Turnbull (Minister for Communications), Nick Xenophon (Independent Senator for South Australia), Christine Milne (Leader of the Australian Greens) and Julie Owens, MP. The undoubted highlight of the event however, was the opportunity for two CNBP scientists, Sabrina Heng and Philipp Reineck to meet with Australian Prime Minster Tony Abbott where they gave a broad overview of their research and the activities of the CNBP more generally.
Philipp Reineck enjoyed the experience noting, “Mr Abbott was very interested in all of our projects and asked a number of relevant questions. He also emphasised the importance of our work and its positive impact on the development of new technologies and on the Australian community as a whole. We were very happy to have had such an insightful and enjoyable meeting with the political leader of our country.”
The CNBP team are already looking forward to next year’s event!
25 March 2015:
Ewa Goldys, CNBP Deputy Director undertook a special seminar for the Vascular Research Centre Group at the South Australian Health and Medical Research Institute (SAHMRI) during a visit on the 25th March, 2015.
Her talk titled, “Non-invasive imaging of biochemistry in cell populations,” looked at the development of specialised characterization hardware and analysis tools using hyperspectral imaging, which is able to identify cells within a population with differing biochemistry. She also discussed how this methodology responds to commercial and clinical needs across a broad spectrum of medicine and the life sciences.
24 March 2015
Congratulations to Prof Andrew Zannettino, Dr Alex Francois and team for winning an $18,000 grant from the University of Adelaide Interdisciplinary Research Fund for their project ‘Diagnosing multipte myeloma: Development of a point of care device for detecting and monitoring serum free light chain levels in serum’.
The project is aiming of using our Whispering Gallery Mode sensor for the detection of light chain antibodies for medical diagnostics applications.
23 March 2015:
CNBP researcher Philipp Reineck suggests that we have much to learn from the chameleon and its ability to glow in technicolour. You can read more about chameleons and their masterful use of natural nanotechnology techniques in COSMOS Magazine.
20 March 2015:
Following an extensive international recruitment search, Professor Mark Hutchinson has today been announced as the Director of the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Council (ARC) Centre of Excellence.
As CNBP Director, Hutchinson leads a $38m funded research centre that is driving the development of new light related technologies and tools that can measure molecules and cellular processes in what is a highly complex and dynamic environment – the living body.
Hutchinson, a Professor within the School of Medical Sciences at the University of Adelaide had previously been acting as interim CNBP Director since September 2014.
“I’m extremely excited and proud to be leading a team of such outstanding researchers,” said Professor Hutchinson. “The technologies and tools being developed by the Centre operate at the nano scale and are literally providing us with ‘windows into the body’. Understanding the processes in the human body at the molecular level will advance our scientific knowledge immensely and will have enormous clinical impact.”
A collaborative research venture, the CNBP is led by the University of Adelaide with key nodes at Macquarie University and RMIT University, and other industry and academic partners located around the world. The cellular and subcellular research being undertaken by the CNBP will have important clinical health outcomes, particularly in the areas of cardiovascular disease, chronic pain and reproduction.
Professor Aidan Byrne, CEO of the Australian Research Council said, “Professor Hutchinson is well-respected in the medical sciences field and will make a great contribution to the ARC Centre of Excellence for Nanoscale BioPhotonics. He will lead his team well and ensure the research programme of the Centre forges ahead and makes important discoveries to the benefit of Australians.”
Since returning to Australia in 2009 from postdoctoral positions in the USA, Professor Hutchinson has led the Neuroimmunopharmacology laboratory within the School of Medical Sciences at the University of Adelaide. He also leads the Biological Sensing and Medical Diagnostics theme within the Institute for Photonics and Advanced Sensing at the University of Adelaide, and is a current board member of Science Technology Australia.
The appointment takes immediate effect.
19 March 2015:
Solid-binding peptides: smart tools for nanobiotechnology;
Andrew Care, Peter L. Bergquist, and Anwar Sunna
Trends Biotechnol. 2015 Mar 19. [Epub ahead of print]
19 March 2015:
CNBP Director Mark Hutchinson argues that a more integrated, transdisciplinary research environment is needed – not just in biophotonics but also across multiple physical and medical scientific disciplines as well. Read more in Electro Optics online – http://www.electrooptics.com/news/news_story.php?news_id=2350.